Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-001246

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Matthew D Perry
Director · Other
Period of report
Apr 28, 2017
Accepted (ET)
May 2, 2017 · 6:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F1Apr 28, 2017M34,736—A43,139D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F3,F2—Apr 28, 2017M34,736D——Common Stock00D
Stock Option (Right to Buy)F1,F4$4.25holding————Feb 22, 2027Common Stock50,00050,000D

Explanation of responses